HSPA9 and neoplasm: Our results have shown that antagonism of mortalin in human K562, MCF-7 and MDA-MB-231 cells by SMRwt peptides allowed the tumor cells to reestablish complement attack, reduced tumor cell growth, and blocked EV release.